14-Oct-16 As the Indian government reviews an overhaul of the drug regulatory process, rules related to clinical trials may be further eased and timelines for approvals shortened to 4-6 months from around 6-8 months now. [image: The Economic Times]

 Webinars

11-Oct-16 Macao in southern China - renowned as Asia's 'Las Vegas' - has tabled plans to become a hub to make traditional Chinese medicine more standardized and scientific, and to further develop it to enable it to be sold around the world. [image: Xinhua]

01-Oct-16 A Chinese government investigation has revealed that more than 80% of the data used in clinical trials of new drugs have been "fabricated". The investigation, led by the SFDA, looked at data from 1,622 clinical trials. The SFDA found that the suspect data failed to meet analysis requirements, were incomplete, or totally non-existent. [image: Plavevski / Shutterstock / Science Alert]

29-Sep-16 Chinese companies have announced more than USD5.2 bn of overseas healthcare acquisitions in 2016, a 15-fold jump from 2012. "Even though China’s pharmaceutical industry is still in the middle of consolidation and price wars, we hope to escape from this and do more work in terms of innovation and internationalization," said Shao Yan, CEO of China Grand Pharma. [image: China Grand Pharmaceutical and Healthcare Holdings Ltd]